Chondrogel: Completed Phase III trial enrollment

Curis Inc. (CRIS), Cambridge, Mass. Product: Chondrogel Business: Biomaterial/Skin/Wound Therapeutic category: Cell replacement Target: NA Description: Autologous cultured cartilage cells Indication: ...